8. Referências Bibliográficas:
1- Abbas AK, Lichtman AH, Pober JS. Effector mechanisms of humoral immunity. In Cellular and Molecular Immunology, 4th Ed., 2000, W. B. Saunders Company, Philadelphia, pp. 309-34.
2- Alves AEM, Costa MRM, Lobato L, Fernandes LM, Azevedo VN, Moreira MRC, Machado LFA, Ishak MOG, Ishak R, Vallinoto ACR. O Impacto do polimorfismo no gene mbl (Mannose-bindinf lectin) na infecção pelo vírus da imunodeficiência humana (HIV). Rev.
Científica UFPA 2004; 4.
3- Aittoniemi J, Miettinen A, Laipalla P, Isolauri E, Viikari J, Ruuska T, Soppi E. Age dependent variation in the serum Concentration of mannan-binding protein. Acta Paediatr. 1996; 85:
906-9.
4- Aittoniemi J, Rintala E, Miettinen A, Soppi E. Serum mannan- binding lectin (MBL) in patients with infection: clinical and laboratory correlates. APMIS 1997; 105:617-22.
5- Amoroso A, Berrino M, Boniotto M, Crovella S, Palomba E, Searlatti G, Serra C, Tovo PA, Vatta S. Polymorphism at codon 54 of mannose-binding protein gene influences AIDS progression but not HIV infection in exposed children. AIDS 1999; 13: 863-64.
6- Arraes LC, Souza P, Castelo A, Moura P, Lima Filho JL, Crovella S. MLB2 mothers’ genotype influences HIV-1 vertical transmission in Brazilian children. JBA 2004; 5: 199-202.
7- Barré-Sinoussi F, Chermann JC, Rey R, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vézinet-Brun F, Rouzioux C, Rozenbaum W, Montagner L. Isolation of T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983; 220: 868-71.
8- Beckerman KP, Morris AB, Stek A. Mode of delivery and the risk of vertical transmission of HIV-1. N. Engl. J. Med. 1999; 341 (3):
205-7.
9- Bohana-Kashtan O, Ziporen L, Donin N, Kraus S, Fishelson Z.
Cell signals transduced by complement. Mol. Immunol. 2004; 41 (6-7):
583-97.
10- Boldt ABW, Petzl-Erler ML. A new strategy for mannose-binding lectin gene haplotyping. Hum. Mutat. 2002; 19: 296-306.
11- Boletim epidemiológico – Ministério da Saúde, 2005.
aids.gov.br /final/dados/BOLETIM.
12- Boniotto M, Crovella S, Pirelli D, Scarlatti G, Spano A, Vatta L, Zezlina S, Tovo PA, Palomba E, Amoroso A. Polymorphisms in the MBL-2 promoter correlated with risk of HIV-1 vertical transmission and AIDS progression. Genes and Immunity 2000; 1: 346-48.
13- Boniotto M, Braida L, Pirulli D, Arraes L, Amoroso A, Crovella S.
MBL2 polymorphisms are involved in Brazilian perinatally infected children. AIDS 2003; 17 (5): 779-80.
14- Botos I, Wlodawer A. Proteins that bind high-mannose sugars of the HIV envelope. Prog. Biophys. Mol. Biol. 2005; 88 (2): 233-82.
15- Boyer V, Desgranges C, Trabaud MA, Fischer E, Kazatchkinel MD. Complement mediates human immunodeficiency vírus type 1 infection of a human T cell line in a CD4 and antibody-independent fashion. J. Exp. Med. 1991; 173: 1151-8.
16- Ministério da Saúde – Recomendações para profilaxia da transmissão vertical do HIV e terapia anti-retroviral em gestantes.
www.aids.gov.br/final/biblioteca/adulta2004/consenso.doc
17- Butter GS, Sim D, Tam E, Devine D, Overall CM. Mannose- binding lectin (MBL) mutants are susceptible to matrix metalloproteinase proteolysis. J. Biol. Chem. 2002; 277 (20): 17511- 19.
18- Ceballos A, de Los Angeles Pando M, Liberatore D, Biglione M, Cardenas PC, Martinez M, Celadilla ML, Avila MM, Peralta LM.
Efficacy of strategies to reduce mother-to-child HIV-1 transmission in Argentina, 1993-2000. J. Acquir. Immune Defic. Syndr. 2002; 31 (3):
348-53.
19- Cedzynski M, Szemraj J, Swierzko AS, Bak-Romaniszyn L, Banasik M, Zeman K, Kilpatrick DC. Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system. Clin. Exp. Immunol. 2004; 136 (2): 304-11.
20- Chin J. Current and future dimensions of the HIV/AIDS pandemic in women and children. Lancet 1990; 336: 221-4.
21- Christiansen OB, Kilpatrick DC, Souter V, Thiel S, Jensenius JC. Mannan-binding lectin deficiency is associated with unexplained recurrent miscarriage. Scand. J. Immunol. 1999; 49: 193.
22- Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, et al.
Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N. Engl. J. Med.
1994;331(18):1173-80.
23- Crosdale DJ, Ollier WE, Thomson W, Dyer PA, Jensenious J, Johnson RW, Poulton KV. Mannose binding lectin (MBL) genotype distributions with relation to serum levels in UK Caucasoids. Eur J Immunogenet. 2000; 27 (3): 111-7.
24- Dahl M, Tybjærg-Hansen A, Schnohr P, Nordestgaard BG. A population-based study of morbidity and mortality in mannose-binding lectin deficiency. J. Exp. Med. 2004; 199 (10): 1391-99.
25- Dierich MO, Ebenbichler CF, Marschang P, Füst G, Thielens NM, Arlaud GJ. HIV and human complement: mechanisms of interaction and biological implication. Immunol. Today 1993; 14: 435- 40.
26- Dunn DT, Tess BH, Rodrigues LC, Ades AE. Mother-to-child transmission of HIV: implications of variation in maternal infectivity.
AIDS 1998; 12: 2211-2216.
27- El Sahly HM, Reich RA, Dou SJ, Musser JM, Graviss EA. The effect of mannose binding lectin gene polymorphisms on susceptibility to tuberculosis in different ethnic groups. Scand. J. Infect. Dis. 2004;
36 (2): 106-8.
28- EZekowitz AB, Day LE, Herman GA. A human mannose- binding protein is an acute-phase reactant that shares sequence
homology with other vertebrate lectins. J. Exp. Med. 1988; 167: 1034- 46.
29- Ezekowitz AB, Kuhlman M, Groopman JE, Byrn RA. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J. Exp. Med. 1989; 169: 185-96.
30- Figueroa JE, Densen P. Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 1991; 4 (3): 359-95.
31- Frank MM. Introduction and Historical Notes. In: Volanakis JE, Frank MM. The human complement system in health and disease.
1998; Marcel Dekker, Inc. New York. pp 1-8.
32- Frank MM. Complement deficiencies. Pediatr. Clin. North. Am.
2000;47(6): 1339-54.
33- Gadjeva M, Thiel S, Jensenius JC. The mannan-binding lectin pathway of the innate immune response. Curr. Opin. Immunol. 2001;
13: 74-8.
34- Garred P, Madsen HO, Hofmann B, Svejgaard A. Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency. Lancet. 1995;
346 (8980): 941-3.
35- Garred P, Madsen Ho, Balslev U, Hofmann B, Pedersen C, Gerstoft J, Svejgaard A. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. The Lancet 1997; 349: 236-40.
36- Ghiran I, Barbashov SF, Klickstein LB, Tas SW, Jensenius JC, Nicholson-Weller A. Complement receptor-1/CD35 is a receptor for mannan-binding lectin. J. Exp. Med. 2000; 192 (12): 1797-807.
37- Greene WC. The molecular biology of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 1991; 324:
308-17.
38- Greene WC. AIDS and the immune system. Sci. Am. 1993;
269: 66-73.
39- Guardia A, Lozano F. Mannose-binding lectin deficiencies in infectious and inflammatory disorders. Rev. Med. Microbiol. 2003; 14:
41-52.
40- Hajela K, Kojima M, Ambrus G, Nick Wong KH, Moffatt BE, Ferluga J, Hajela S, Gae P, Sim RB. The biological functions of MBL- associated serine proteases (MASPs). Immunobiol. 2002; 205: 467- 75.
41- Haurum JS, Thiel S, Jones IM, Fischer PB, Laursen SB, Jensenius JC. Complement activation upon binding of mannan- binding protein to HIV envelope glycoproteins. AIDS 1993; 7 (10):
1307-13.
42- Holmskov U, Malhotra R, Sim RB, Jensenius JC. Collectins:
Collagenous C-type Lectins of Innate Immune Defense System.
Immunol. Today 1994; 15: 67-74.
43- Holmskov U, Thiel S, Jensenius JC. Collectins and ficollins:
Humoral lectins of the innate immune defense. Annu. Rev. Immunol.
2003; 21: 547-78.
44- Jack DL, Klein NJ, Turner MW. Mannose-binding lectin:
targeting the microbial world for complement attack and opsonophagocytosis. Immunol. Rev. 2001; 180: 86-99.
45- Jack DL, Turner MW. Anti-microbial activities of mannose- binding lectin. Biochemical Society Transactions 2003; 31: 753-57.
46- Janeway Junior JC, Travers P, Walport M, Shlomchi K.
Immunobiology: the immune system in healthy and disease. 6th Ed.
New York, Gerland Science. 2005; p. 8.1-8.52.
47- Ji X, Gewurz H, Spear GT. Mannose binding lectin (MBL) and HIV.
Mol. Immunol. 2005; 42 (2): 145-52.
48- Joiner KA, Hawuger A, Gelfand JA. A study of Optimal Reaction Conditions for an Assay of The Human Alternative Complement Pathway. Am. J. Clin. Pathol. 1983; 79: 65-72.
49- Kilpatrick DC, Liston WA, Midgley PC. Mannan binding protein in human umbilical cord blood. Nat. Immun. 1996-97; 15: 234-40.
50- Kilpatric DC. Mannan-binding lectin concentration during normal human pregnancy. Hum Reprod. 2000; 15 (4): 941-43.
51- Kilpatric DC. Manan-binding lectin and its role in innete immunity. Transf. Med. 2002; 12: 335-51.
52- Kilpatrick DC, Mclintock LA, Allan EK, Copland M, Fujita T, Jordanides NE, Koch C, Matsushita M, Shiraki H, Stewart K, Tsujimura M, Turner ML, Franklin IM, Holyoake TL. No strong relationship between mannan binding lectin or plasma ficolins and
chemoteraphy-related infections. Clin. Exp. Immunol. 2003; 134: 279- 84.
53- Klein J. The major histocompatibility complex. In Immunology, 1st Ed., 1990, BSP Inc., Massachusetts, pp. 161-87.
54- Koch A, Melbye M, Sorensen P, Homoe P, Madsen HO, Molbak K, Hansen CH, Andersen LH, Hahn GW, Garred P. Acute Respiratory Tract Infections and Mannose-Binding Lectin Insifficiency During Early Childhood. JAMA 2001; 285 (10): 1316-321.
55- Kotinik V, Luznik-Bufon T, Schneider PM, Kirschfink M.
Molecular, genetic, and functional analysis of homozygous C8β-chain deficiency in two siblings. Immunopharmacol. 1997; 38: 215-21.
56- Landis JR, Kock GG. The measurement of observer agrrement for contrats among multinomial populations. Biometrics, 1977; 33:
159-74.
57- Levi GC, Vitoria MAA. Fighting against AIDS: the Brazilian experience. AIDS 2002; 16: 2373-83.
58- Lian YC, Della-Negra M, Rutz R, Ferriani V, Moraes- Vasconcelos D, Duarte AJS, Kirschfink M, Grumach AS.
Immunological analisis in pediatric HIV patients at different stages of the disease. Scan. J. Immunol. 2004; 60 (6): 615-24.
59- Lipscombe RJ, Sumiya M, Hill AV, Lau YL, Levinsky RJ, Summerfield JA, Turner MW. High frequencies in African and non- African populations of independent mutations in the mannose binding protein gene. Hum. Mol. Genet. 1992; 1 (9): 709-15.
60- Lyall EG, Stainsby C, Taylor GP, Ait-Khaled M, Bingham S, Evans JA, Wright A, Weber JN, McClure MO, Walters S, Tudor- Williams G. Review of uptake of interventions to reduce mother to child transmission of HIV by women aware of their HIV status. BMJ.
1998; 316 (7127): 268-70.
61- Maas J, Husman AMR, Brouwer M, Krol A, Coutinho R, Keet I, Leeuwen RV, Schuitemaker H. Presence of the variant mannose- binding lectin alleles associated with slower progression to AIDS.
AIDS 1998; 12: 2275-80.
62- Madsen HO, Garred P, Thiel S, Kurtzhals JAL, Lamm LU, Ryder LP, Svejgaard A. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J.
Immunol. 1995; 155: 3013-20.
63- Madsen HO, Satz ML, Hogh B, Svejgaard A, Garred P.
Different molecular events result in low protein levels of mannan- binding lectin in populations from southeast Africa and South America.
J Immunol. 1998; 161 (6): 3169-75.
64- Magder LS, Mofenson L, Paul ME, Zorrilla CD, Blattner WA, Tuomala RE, LaRussa P, Landesman S, Rich KC. Risk factors for in utero and intrapartum transmission of HIV. J. Acquir. Immune Defic.
Syndr. 2005; 38 (1): 87-95.
65- Malik S, Arias M, Di-Flumeri C, Garcia LF, Schurr E. Absence of association between mannose-binding lectin gene polymorphisms and HIV-1 infection in a Colombian population. Immunogenetics 2003;
55 (1): 49-52.
66- Miller EM, Seals J, Kaye R, Levtsky LC. A Familial, Plasma- Associated Defect of Phagocytosis. The Lancet 1968; 13: 60-7.
67- Minchinton RM, Dean MM, Clark TR, Heatley S, Mullighan CG.
Analysis of the relationship between mannose-binding lectin (MBL) genotype, MBL levels and function in an Australian blood donor population. Scand J Immunol. 2002; 56 (6): 630-41.
68- Mullighan CG, Marshal SE, Welsh KI. Mannose binding lectin polymorphisms are associated with early age of disease onset and autoimmunity in Common Variable Immunodeficiency. Scand. J.
Immunol. 2000; 51: 111-22.
69- Newell ML. Mechanisms and timing of mother-to-child transmission of HIV-1. AIDS 1998; 12: 831-7.
70- Nielsen SL, Andersen PL, Koch C, Jensenius JC, Thiel S. The level of the serum opsonin, mannan-binding protein in HIV-1 antibody positive patients. Clin. Exp. Immunol. 1995; 100: 219-22.
71- Nolan ML, Greenberg AE, Fowler MG. A review of clinical trials to prevent mother-to-child HIV-1 transmission in Africa and inform rational intervention strategies. AIDS. 2002; 16 (15): 1991-9.
72- Ogden CA, de Cathelineau A, Hoffman PR, Braton D, Ghebrehiwet B, Fadok VA, Henson PM. C1q and mannose-binding lectin engagement of cell surface calreticulin and CD91 iniciates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 2001;
194 (6): 781-95.
73- Ohtani K, Suzuki Y, Eda S, Kawai T, Kase T, Yamazaki H, Shimada T, Keshi H, Sakai Y, Fukuoh A, Sakamoto T, Wakamiya N.
Molecular cloning of a novel human collectin from liver (CL-L1). J. Biol.
Chem. 1999; 274 (19): 13681-9.
74- Ohtani K, Suzuki Y, Eda S, Kawai T, Kase T, Keshi H, Sakai Y, Fukuoh A, Sakamoto T, Itabe H, Suzutani T, Ogasawara M, Yoshida I, Wakamyia N. The membrane type collectin CL-P1 is a scavenger receptor on vascular endothelial cells. J. Biol. Chem. 2001; 276 (47):
44222-8.
75- Pancharoen C, Thisyakorn U. Pediatric acquired immunodeficiency syndrome in Asia: mother-to-child transmission.
Clin. Infect. Dis. 2002; 34 (Suppl 2): S65-9.
76- Pavlakis GN. The molecular biology of Human Immunodeficiency Virus Type 1. In: De Vita Jr. VT, Hellman S, Rosenberg SA. AIDS: Biology, Diagnostic Treatment and Prevention.
4th Ed. Lippincott-Raven Publishers. 1997 p. 45-67.
77- Perricone R, Fontana L, De Carolis C, Carini C, Sirianni MC, Aiuti F. Evidence for activation of complement in patients with AIDS related complex (ARC) and/or lymphoadenopathy syndrome (LAS).
Clin. Exp. Immunol. 1987; 70: 500-7.
78- Petersen SV, Thiel S, Jensenius JC. The mannan-binding lectin pathway of complement activation: biology and disease association. Mol. Immunol. 2001a; 38: 133-49.
79- Petersen SV, Thiel S, Jensen L, Steffensen R, Jensenius JC.
An assay for the mannan-binding lectin pathway of complement activation. J. Immunol. Meth. 2001b; 257: 107-16.
80- Polotsky VY, Belisle JT, Mikusova K, Ezekowitz RA, Joiner KA.
Interaction of human mannose-binding protein with Mycobacterium avium. J Infect Dis. 1997; 175 (5): 1159-68.
81- Prodinger WN, Würzner R, Erdei A, Dierich MP. Complement in W and PAUL. Fundamental Immunology, 4th Ed., 1998, Lippincott Willians and Wilkins, Philadelphia.
82- Prodinger WM, Würzner R, Stoiber H, Dierich MP.
Complement. In: Paul WE. Fundamental Immunology. 5th Ed.
Lippincott Williams and Wilkins. Philadelphia, 2003; pp. 1077-103.
83- Prohaszka Z, Thiel S, Ujhelyi E, Szlávik J, Bánhegyi D, Füst G.
Mannan-binding lectin serum concentration in HIV-infected patients are influenced by stage of disease. Immunol. Lett. 1997a; 58: 171-5.
84- Prohaszka Z, Toth FD, Banhegyi D, Fust G. Role of Complement and Antibodies in the Control and Facilitation of HIV Disease. Pathol. Oncol. Res. 1997b; 3(4): 296-302.
85- Reid KBM. C1q and mannose-binding lectin in VOLANAKIS JE, FRANK MM. The Human Complement System in Health and Disease. 1998, Marcel Dekker, Inc., New York, pp. 33-48.
86- Remington RD, SchorkMA. Statistics with applications to Biology, Biological and health sciencies. Pretince – Hall, Inc., Englewood Cliffs New Jersey. 1970.
87- 1994 REVISED Classification System for Human Immunodeficiency Virus Infection in Children Less than 13 Years of Age. MMWR Morb. Mortal. Wkly. Rep. 1994; 43: 1-19.
88- 1993 REVISED Classification System for Human Immunodeficiency Virus Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. MMWR 1992;
41(RR-17): 1-13.
89- Roos A, Garred P, Wildenberg ME, Lynch NJ, Munoz JR, Zuiverloon TC, Bouwman LH, Schlagwein N, Fallaux van den Houten FC, Faber-Krol MC, Madsen HO, Schwaeble WJ, Matsushita M, Fujita T, Daha MR. Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiency.
Eur. J. Immunol. 2004; 34 (9): 2589-98.
90- Rother K, Rother U, Hänsch G. The role of complement in Inflamation. Path. Res. Pract. 1985; 180: 117-24.
91- Rus HG, Niculescu FI, Shin ML. Role of the C5b-9 complement complex in cell cycle and apoptosis. Immunol Rev. 2001;
180: 49-55.
92- Saiffudin M, Hart ML, Gewurz H, Zhang Y, Spear GT.
Interaction of Mannose-Binding Lectin with Primary Isolates of HIV type 1. J. Gen. Virol. 2000; 81: 949-55.
93- São Paulo (Município). Programa DST/AIDS. Boletim epidemiol. AIDS; 1997, 1 (1).
94- Sasaki K, Tsutsumi A, Wakamiya N, Ohtani K, Suzuki Y, Watanabe Y, Nakayama N, Koike T. Mannose-binding lectin polymorphisms in patients with hepatitis C virus infection. Scand J Gastroenterol. 2000; 35 (9): 960-5.
95- Sastry K, Ezekowitz RA. Collectins: pattern recognition molecules involved in first line host defense. Curr. Opin. Immunol.
1993; 5 (1): 59-66.
96- Schwaeble W, Dahl MR, Thiel S, Stover C, Jensenius JC. The mannan-binding lectin-associated serine proteases (MASPs) and MAp19: four components of the lectin pathway activation complex encoded by two genes. Immunobiol. 2002; 205 (4-5): 455-66.
97- Senaldi G, Davies ET, Mahalingam M, Lu J, Pozniak A, Peakman M, Reid KB, Vergani D. Circulating levels of mannose binding protein in human immunodeficiency virus infection. J. Infect.
1995; 31: 145-48.
98- Siegel S, Castellan Jr NJ. Nonparametric statistics. 2sd Edition.
McGraw, Hill. Int. Ed., N. York, 1988: 399.
99- Site do Ministério da Saúde – Guia de tratamento da infecção pelo HIV em crianças - 2000: www.aids.gov.br
100- Soborg C, Madsen HO, Andersen AB, Lillebaek T, Kok-Jensen A, Garred P. Mannose-binding lectin polymorphisms in clinical tuberculosis. J. Infect. Dis. 2003; 188 (5): 777-82.
101- Soothill JF, Harvey BAM. Defective opsonization: a common immunity deficiency. Arch. Dis. Child. 1976; 51: 91-99.
102- Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD, O'Sullivan MJ, Van Dyke RB, Jimenez E, Rouzioux C, Flynn PM, Sullivan JL. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from
mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1996; 335 (22): 1621-9.
103- Speth C, Kacani L, Dierich MP. Complement receptors in HIV infection. Immunol. Rev. 1997; 159: 49-67.
104- St Louis ME, Kamenga M, Brown C, Nelson AM, Manzila T, Batter V, Behets F, Kabagabo U, Ryder RW, Oxtoby M, et al. Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors. JAMA. 1993; 269 (22): 2853-9.
105- Steffensen R, Thiel S, Varming K, Jersild C, Jensenius JC.
Detection of structural gene mutation and promoter polymorphisms in the mannan-binding lectin (MBL) gene by a polymerase chain reaction with sequence-specific primers. J. Immunol. Meth. 2000; 241: 33-42.
106- Steffensen R, Hoffmann K, Varming K. Rapid genotyping of MBL2 gene mutations using real-time PCR with fluorescent hybridization probes. J. Immunol. Meth. 2003; 278: 191-99.
107- Stengaard-Pedersen K, Thiel S, Gadjeva M, Moller-Kristensen M, Sorensen R, Jensen LT, Sjoholm AG, Fugger L, Jensenius JC.
Inherited deficiency of mannan-binding lectin-associated serine protease 2. N Engl J Med. 2003; 349 (6): 554-60.
108- Stoiber H, Pintér C, Siccardi AG, Clivio A, Dierich MP.
Efficiente destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55). J. Exp. Med. 1996; 183 (1):
307-10.
109- Stoiber H, Pruenster M, Ammann CG, Dierich MP.
Complement-opsonized HIV: the free rider on its way to infection. Mol.
Immunol. 2005; 42 (2): 153-60.
110- Sullivan KE, Wooten C, Goldman D, Petri M. Mannose-binding protein genetic polymorphisms in black patients with systemic lupus Erythematosus. Arthritis Rheum. 1996; 39: 2046.
111- Sumiya M, Super M, Tabona P, Levinsky RJ, Arai T, Turner MW, Summerfield JA. Molecular basis of opsonic defect in immunodeficient children. Lancet. 1991 29; 337 (8757): 1569-70.
112- Summerfield JA, Ryder S, Sumiye M, Thursz M, Gorchein A, Monteil MA, Turner MW. Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet 1995;
345 (8):886-9.
113- Supper M, Lu J, Thiel S, Levinski RJ, Turner MW. Association of Low Levels of Mannan-Binding Protein with a Common Defect of Opsonization. Lancet 1989; 25: 1236-9.
114- Szabo J, Cervenak L, Toth FD, Prohaszka Z, Horvath L, Kerekes K, Beck Z, Bacsi A, Erdei A, Peerschke EI, Fust G, Ghebrehiwet B. Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures. Clin Immunol. 2001; 99 (2): 222-31.
115- Taha TE, Nour S, Kumwenda NI, Broadhead RL, Fiscus SA, Kafulafula G, Nkhoma C, Chen S, Hoover DR. Gender differences in perinatal HIV acquisition among African infants. Pediatrics. 2005;115 (2): e167-72.
116- Ten RM, Carmona EM, Babovic-Vuksanovic D, Katzmann JA.
Mannose-binding lectin deficiency associated with neutrophil chemotatic unresponsiveness to C5a. J. Allergy. Clin. Immunol. 1999;
104(2): 419-24.
117- Thiel S, Holmskov U, Hviid L, Laursen SB, JenseniuS JC. The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin. Exp.
Immunol. 1992; 90: 31-5.
118- Thiel S, Bjerke T, Hansen D, Poulsen LK, Schiotz PO, Jensenius JC. Ontogeny of human mannan-binding lectin protein, a lectin of the immune system. Pediatr. Allergy Immunol. 1995; 6: 20-3.
119- Thielens NM, Delorme PT, Arlaud GJ. Interaction of C1q and manna-binding lectin with viruses. Immunobiol. 2002; 205: 563-74.
120- Turner MW. Mannose-Binding Lectin: The Pluripotent Molecule of The Innate Immune System. Immunol. Today 1996; 17 (11): 532- 40.
121- Vermelho LL, Silva LP, Costa AJL. Epidemiologia da transmissão vertical do HIV no Brasil. National coordination of Std/Aids, Minister of Health, Brasília
(http://www.aids.gov.br/udtv/boletim_jun_ago99/trans_vertical.htm).
122- Volanakis JE. Overview of the complement system. In Volanakis JE, Frank MM. The human complement system in healthy and disease. New York, Marcel Dekker, 1998; p. 9-32.
123- Waage NE, Thidemann JH, Hadasen K, Wuillemin W, Hack CE, Mollnes TE. Activation of Complement, Coagulation, Fibrinolytic and Kallikrein-Kinin Systems During Attacks of Hereditary Angioedema. Scand. J. Immunol. 1996; 44:185-92.
124- Wallis R, Dodd RB. Interaction of mannose-binding protein with associated serine proteases. J. Biol. Chemistry 2000; 275(40): 30962- 9.
125- Wallis R. Structural and functional aspects of complement activation by mannose-binding protein. Immunobiol. 2002; 205 (4-5):
433-45.
126- Walport MJ. Advances in Immunology; Complement (first of two parts). New Eng. J. Med. 2001; 344 (14): 1058-66.
127- Winkelstein J, Gewurz AT, Lint TF, Gewurz H. The complement system. In: Adkinson Jr NF, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FER. Allergy principles and practice, 6th Ed.
Mosby Inc., Philadelphia, 2003; pp: 66-85.
128- Zar JH. Bioestatistical Analysis. Prentice, Hall, Inc. Englewood, 3rd Ed., 1996: 718.
